PKIS v2.0 A clinical tool for identifying important pharmacokinetic drug-drug interactions
| 1. Accepted major perpetrators | 2. Rejected perpetrators | 3. Unclassifiable | 4. Full table |


  • norethindrone is not available in Australia/New Zealand, despite evidence suggesting that it may perturb the activities of CYP2C19.
  • CYP2C19
    Not available in Australia or New Zealandarmodafinil

    Footnotes and References

    WARNING: While all efforts were put in to maintain the accuracy and currency of the information, it is possible that the knowledge and electronic tools may contain errors and inadequacy. Both Flinder's University and University of New South Wales are not liable to any damages or losses resulted from such circumstances. Clinical discretions are strongly advised at all times.